Pluri (PLUR) Long-Term Investments (2012 - 2022)
Pluri (PLUR) reported Long-Term Investments of $4.2 million for Q1 2022, down 83.67% year-over-year from $25.9 million in Q1 2021, and down 61.38% quarter-over-quarter from $11.0 million in Q4 2021.
Pluri (PLUR) Long-Term Investments (2012 - 2022) Analysis & Trends
Pluri (PLUR) has 11 years of Long-Term Investments data on file, last reported at $4.2 million in Q1 2022.
- Long-Term Investments for Q1 2022 came in at $4.2 million, down 83.67% year-over-year; the trailing twelve-month figure through Mar 2022 was $4.2 million (down 83.67% YoY), and the FY2021 annual result was $23.3 million, up 89.97% from the prior year.
- Long-Term Investments eased to $4.2 million in Q1 2022 per PLUR's latest filing, from $11.0 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $25.9 million in Q1 2021 and troughed at $379000.0 in Q4 2018.
- A 5-year average of $6.7 million and a median of $409000.0 in 2019 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2021 and 2022: Long-Term Investments surged 6449.75% in 2021, then slumped 83.67% in 2022.
- A 5-year view of Long-Term Investments shows it stood at $379000.0 in 2018, then advanced by 7.92% to $409000.0 in 2019, then soared by 670.66% to $3.2 million in 2020, then surged by 247.87% to $11.0 million in 2021, then plunged by 61.38% to $4.2 million in 2022.
- Business Quant data shows PLUR's Long-Term Investments at $4.2 million in Q1 2022, $11.0 million in Q4 2021, and $18.5 million in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 4.24 Mn |
| Dec 31, 2021 | 10.97 Mn |
| Sep 30, 2021 | 18.48 Mn |
| Jun 30, 2021 | 23.27 Mn |
| Mar 31, 2021 | 25.94 Mn |
| Dec 31, 2020 | 3.15 Mn |
| Sep 30, 2020 | 12.13 Mn |
| Jun 30, 2020 | 12.25 Mn |
| Mar 31, 2020 | 396,000.00 |
| Dec 31, 2019 | 409,000.00 |
| Sep 30, 2019 | 408,000.00 |
| Jun 30, 2019 | 398,000.00 |
| Mar 31, 2019 | 391,000.00 |
| Dec 31, 2018 | 379,000.00 |
| Sep 30, 2018 | 385,000.00 |
| Jun 30, 2018 | 383,000.00 |
| Mar 31, 2018 | 398,000.00 |
| Dec 31, 2017 | 403,000.00 |
| Sep 30, 2017 | 397,000.00 |
| Jun 30, 2017 | 403,000.00 |